Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Grimes Scott D.. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Grimes Scott D. har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:CDLX / Cardlytics, Inc. | Director | 248 779 |
US:EVRG / Evergy, Inc. | Director | 13 666 |
US:GXP / Great Plains Energy, Inc. | Director | 0 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Grimes Scott D.. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp CDLX / Cardlytics, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i CDLX / Cardlytics, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel CDLX / Cardlytics, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i CDLX / Cardlytics, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Grimes Scott D. som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-11-10 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −6 | 248 779 | 0,00 | 3,92 | −24 | 975 214 | |
2022-11-08 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −494 | 248 785 | −0,20 | 3,98 | −1 969 | 991 408 | |
2022-11-08 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −9 002 | 249 279 | −3,49 | 4,32 | −38 889 | 1 076 885 | |
2022-11-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 19 687 | 258 281 | 8,25 | ||||
2022-08-08 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −9 257 | 238 594 | −3,73 | 15,19 | −140 614 | 3 624 243 | |
2022-07-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 19 688 | 247 560 | 8,64 | ||||
2022-05-09 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −7 936 | 227 872 | −3,37 | 34,63 | −274 824 | 7 891 207 | |
2022-05-09 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −7 798 | 235 808 | −3,20 | 34,14 | −266 224 | 8 050 485 | |
2022-04-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −4 098 | 243 606 | −1,65 | 50,09 | −205 269 | 12 202 225 |
2022-04-07 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −19 688 | 19 687 | −50,00 | ||||
2022-04-07 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 19 688 | 247 704 | 8,63 | ||||
2022-04-07 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
M - Exercise | −3 408 | 10 227 | −24,99 | ||||
2022-04-07 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 3 408 | 228 016 | 1,52 | ||||
2022-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −400 | 224 608 | −0,18 | 58,09 | −23 236 | 13 047 479 |
2022-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 100 | 225 008 | −1,36 | 57,40 | −177 940 | 12 915 459 |
2022-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 500 | 228 108 | −1,08 | 56,40 | −141 000 | 12 865 291 |
2022-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
M - Exercise | −14 920 | 29 840 | −33,33 | ||||
2022-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 14 920 | 230 608 | 6,92 | ||||
2022-03-24 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
A - Award | 1 660 | 215 688 | 0,78 | ||||
2022-03-24 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
A - Award | 31 152 | 44 787 | 228,47 | ||||
2022-03-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −800 | 214 028 | −0,37 | 54,91 | −43 928 | 11 752 277 |
2022-03-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −4 600 | 214 828 | −2,10 | 54,03 | −248 538 | 11 607 157 |
2022-03-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −600 | 219 428 | −0,27 | 52,93 | −31 758 | 11 614 324 |
2022-03-07 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −24 | 220 028 | −0,01 | 60,79 | −1 459 | 13 375 502 |
2022-03-07 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 100 | 220 052 | −0,50 | 59,75 | −65 725 | 13 148 107 |
2022-03-07 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 862 | 221 152 | −0,83 | 58,69 | −109 281 | 12 979 411 |
2022-03-07 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 574 | 223 014 | −0,70 | 58,08 | −91 418 | 12 952 653 |
2022-03-07 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 440 | 224 588 | −0,64 | 56,82 | −81 821 | 12 761 090 |
2022-02-23 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 226 028 | −0,13 | 60,61 | −18 183 | 13 699 557 |
2022-02-23 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −899 | 226 328 | −0,40 | 59,77 | −53 733 | 13 527 625 |
2022-02-23 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 175 | 227 227 | −0,51 | 58,81 | −69 102 | 13 363 220 |
2022-02-23 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 626 | 228 402 | −1,56 | 57,86 | −209 800 | 13 215 340 |
2022-02-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 232 028 | −0,04 | 65,58 | −6 558 | 15 216 396 |
2022-02-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 642 | 232 128 | −0,70 | 64,73 | −106 287 | 15 025 645 |
2022-02-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 784 | 233 770 | −1,18 | 63,75 | −177 480 | 14 902 838 |
2022-02-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 474 | 236 554 | −0,62 | 62,88 | −92 685 | 14 874 516 |
2022-01-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 600 | 238 028 | −0,67 | 63,42 | −101 472 | 15 095 736 |
2022-01-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 269 | 239 628 | −1,35 | 62,75 | −205 130 | 15 036 657 |
2022-01-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 131 | 242 897 | −0,46 | 61,71 | −69 794 | 14 989 174 |
2022-01-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −603 | 244 028 | −0,25 | 68,73 | −41 444 | 16 772 044 |
2022-01-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 700 | 244 631 | −0,69 | 68,11 | −115 787 | 16 661 817 |
2022-01-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −600 | 246 331 | −0,24 | 66,79 | −40 074 | 16 452 447 |
2022-01-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 897 | 246 931 | −0,76 | 65,93 | −125 069 | 16 280 161 |
2022-01-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 200 | 248 828 | −0,48 | 64,86 | −77 832 | 16 138 984 |
2021-12-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 250 028 | −0,08 | 64,66 | −12 932 | 16 166 810 |
2021-12-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 300 | 250 228 | −0,52 | 63,88 | −83 044 | 15 984 565 |
2021-12-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 498 | 251 528 | −0,98 | 62,73 | −156 700 | 15 778 351 |
2021-12-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 002 | 254 026 | −0,78 | 61,96 | −124 044 | 15 739 451 |
2021-12-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −400 | 53 112 | −0,75 | 66,00 | −26 400 | 3 505 392 |
2021-12-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −320 | 53 512 | −0,59 | 65,12 | −20 838 | 3 484 701 |
2021-12-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −640 | 53 832 | −1,17 | 63,88 | −40 883 | 3 438 788 |
2021-12-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −640 | 54 472 | −1,16 | 63,03 | −40 339 | 3 433 370 |
2021-12-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
W - Other | 55 832 | 55 832 | |||||
2021-12-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 450 | 256 028 | −0,56 | 69,34 | −100 543 | 17 752 982 | |
2021-12-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −10 645 | 257 478 | −3,97 | 68,64 | −730 673 | 17 673 290 | |
2021-12-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −6 211 | 268 123 | −2,26 | 67,61 | −419 926 | 18 127 796 | |
2021-12-13 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −39 375 | 39 375 | −50,00 | ||||
2021-12-13 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
A - Award | 78 750 | 78 750 | |||||
2021-12-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 39 375 | 274 334 | 16,76 | ||||
2021-12-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 234 959 | −0,04 | 65,20 | −6 520 | 15 319 327 |
2021-12-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 235 059 | −0,13 | 64,06 | −19 218 | 15 057 880 |
2021-12-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −684 | 235 359 | −0,29 | 62,99 | −43 085 | 14 825 263 |
2021-12-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 816 | 236 043 | −1,59 | 62,23 | −237 470 | 14 688 956 |
2021-12-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 100 | 239 859 | −0,46 | 61,43 | −67 573 | 14 734 538 |
2021-12-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 55 112 | −0,54 | 65,23 | −19 569 | 3 594 956 |
2021-12-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 700 | 55 412 | −2,98 | 64,34 | −109 378 | 3 565 208 |
2021-11-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 240 959 | −0,08 | 83,11 | −16 622 | 20 026 102 |
2021-11-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −500 | 241 159 | −0,21 | 82,34 | −41 170 | 19 857 032 |
2021-11-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −310 | 241 659 | −0,13 | 80,97 | −25 101 | 19 567 129 |
2021-11-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 900 | 241 969 | −0,78 | 79,88 | −151 772 | 19 328 484 |
2021-11-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −617 | 243 869 | −0,25 | 78,48 | −48 422 | 19 138 839 |
2021-11-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −500 | 244 486 | −0,20 | 77,27 | −38 635 | 18 891 433 |
2021-11-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −871 | 244 986 | −0,35 | 76,03 | −66 222 | 18 626 286 |
2021-11-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 102 | 245 857 | −0,45 | 75,16 | −82 826 | 18 478 612 |
2021-11-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −711 | 57 112 | −1,23 | 87,14 | −61 957 | 4 976 740 |
2021-11-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −489 | 57 823 | −0,84 | 86,16 | −42 132 | 4 982 030 |
2021-11-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −800 | 58 312 | −1,35 | 85,39 | −68 312 | 4 979 262 |
2021-11-08 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 200 | 246 865 | −0,48 | 92,95 | −111 540 | 22 946 102 | |
2021-11-08 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 500 | 248 065 | −0,60 | 92,31 | −138 465 | 22 898 880 | |
2021-11-08 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −5 991 | 249 565 | −2,34 | 90,41 | −541 646 | 22 563 172 | |
2021-11-08 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −9 493 | 255 556 | −3,58 | 90,13 | −855 604 | 23 033 262 | |
2021-11-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −40 | 59 112 | −0,07 | 81,74 | −3 270 | 4 831 815 |
2021-11-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −821 | 59 152 | −1,37 | 80,99 | −66 493 | 4 790 720 |
2021-11-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −280 | 59 973 | −0,46 | 80,15 | −22 442 | 4 806 836 |
2021-11-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −399 | 60 253 | −0,66 | 79,17 | −31 589 | 4 770 230 |
2021-11-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −460 | 60 652 | −0,75 | 78,07 | −35 912 | 4 735 102 |
2021-10-19 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −302 | 61 112 | −0,49 | 84,07 | −25 389 | 5 137 686 |
2021-10-19 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 698 | 61 414 | −2,69 | 83,57 | −141 902 | 5 132 368 |
2021-10-06 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −39 375 | 39 375 | −50,00 | ||||
2021-10-06 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
A - Award | 78 750 | 78 750 | |||||
2021-10-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 39 375 | 265 049 | 17,45 | ||||
2021-10-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −557 | 63 112 | −0,87 | 82,04 | −45 696 | 5 177 708 |
2021-10-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −138 | 63 669 | −0,22 | 81,12 | −11 195 | 5 164 829 |
2021-10-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −501 | 63 807 | −0,78 | 80,00 | −40 080 | 5 104 560 |
2021-10-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −804 | 64 308 | −1,23 | 78,98 | −63 500 | 5 079 046 |
2021-09-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 000 | 225 674 | −1,31 | 90,00 | −270 000 | 20 310 660 |
2021-09-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 65 112 | −0,15 | 92,83 | −9 283 | 6 044 347 |
2021-09-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −809 | 65 212 | −1,23 | 92,09 | −74 501 | 6 005 373 |
2021-09-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 091 | 66 021 | −1,63 | 90,98 | −99 259 | 6 006 591 |
2021-09-07 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −342 | 228 674 | −0,15 | 98,99 | −33 855 | 22 636 439 |
2021-09-07 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 895 | 229 016 | −0,82 | 97,99 | −185 691 | 22 441 278 |
2021-09-07 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −763 | 230 911 | −0,33 | 97,18 | −74 148 | 22 439 931 |
2021-09-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −691 | 67 112 | −1,02 | 97,31 | −67 241 | 6 530 669 |
2021-09-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 060 | 67 803 | −1,54 | 96,88 | −102 693 | 6 568 755 |
2021-09-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −249 | 68 863 | −0,36 | 95,04 | −23 665 | 6 544 740 |
2021-08-30 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 000 | 231 674 | −1,28 | 90,00 | −270 000 | 20 850 660 |
2021-08-19 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −500 | 69 112 | −0,72 | 78,90 | −39 450 | 5 452 937 |
2021-08-19 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 500 | 69 612 | −2,11 | 78,09 | −117 135 | 5 436 001 |
2021-08-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −400 | 234 674 | −0,17 | 121,62 | −48 648 | 28 541 052 |
2021-08-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −326 | 235 074 | −0,14 | 118,88 | −38 755 | 27 945 597 |
2021-08-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −401 | 235 400 | −0,17 | 117,76 | −47 222 | 27 720 704 |
2021-08-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 346 | 235 801 | −0,57 | 116,75 | −157 146 | 27 529 767 |
2021-08-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −527 | 237 147 | −0,22 | 115,98 | −61 121 | 27 504 309 |
2021-08-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 71 112 | −0,14 | 128,09 | −12 809 | 9 108 736 |
2021-08-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −910 | 71 212 | −1,26 | 127,15 | −115 706 | 9 054 606 |
2021-08-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −600 | 72 122 | −0,83 | 126,45 | −75 870 | 9 119 827 |
2021-08-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −390 | 72 722 | −0,53 | 124,39 | −48 512 | 9 045 890 |
2021-07-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 237 674 | −0,04 | 120,47 | −12 047 | 28 632 587 |
2021-07-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −205 | 237 774 | −0,09 | 118,79 | −24 352 | 28 245 173 |
2021-07-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 695 | 237 979 | −0,71 | 117,62 | −199 366 | 27 991 090 |
2021-07-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 000 | 239 674 | −0,42 | 116,67 | −116 670 | 27 962 766 |
2021-07-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 73 112 | −0,27 | 127,39 | −25 478 | 9 313 738 |
2021-07-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −620 | 73 312 | −0,84 | 126,51 | −78 436 | 9 274 701 |
2021-07-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 73 932 | −0,27 | 125,16 | −25 032 | 9 253 329 |
2021-07-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −298 | 74 132 | −0,40 | 123,34 | −36 755 | 9 143 441 |
2021-07-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −682 | 74 430 | −0,91 | 122,63 | −83 634 | 9 127 351 |
2021-07-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 75 112 | −0,27 | 129,83 | −25 966 | 9 751 791 |
2021-07-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 75 312 | −0,40 | 124,92 | −37 476 | 9 407 975 |
2021-07-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −572 | 75 612 | −0,75 | 123,57 | −70 682 | 9 343 375 |
2021-07-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −928 | 76 184 | −1,20 | 122,86 | −114 014 | 9 359 966 |
2021-06-24 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −285 | 240 674 | −0,12 | 127,01 | −36 198 | 30 568 005 |
2021-06-24 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −601 | 240 959 | −0,25 | 126,31 | −75 912 | 30 435 531 |
2021-06-24 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 014 | 241 560 | −0,42 | 125,35 | −127 105 | 30 279 546 |
2021-06-24 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 242 574 | −0,04 | 123,64 | −12 364 | 29 991 849 |
2021-06-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −417 | 77 112 | −0,54 | 105,19 | −43 864 | 8 111 411 |
2021-06-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −643 | 77 529 | −0,82 | 104,39 | −67 123 | 8 093 252 |
2021-06-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −940 | 78 172 | −1,19 | 103,45 | −97 243 | 8 086 893 |
2021-06-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −99 | 79 112 | −0,12 | 107,36 | −10 629 | 8 493 464 |
2021-06-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −885 | 79 211 | −1,10 | 106,29 | −94 067 | 8 419 337 |
2021-06-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 016 | 80 096 | −1,25 | 105,53 | −107 218 | 8 452 531 |
2021-05-25 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −20 | 242 674 | −0,01 | 101,00 | −2 020 | 24 510 074 |
2021-05-25 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 370 | 242 694 | −0,56 | 100,49 | −137 671 | 24 388 320 |
2021-05-25 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −510 | 244 064 | −0,21 | 99,57 | −50 781 | 24 301 452 |
2021-05-25 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −40 | 244 574 | −0,02 | 98,32 | −3 933 | 24 046 516 |
2021-05-25 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −60 | 244 614 | −0,02 | 96,86 | −5 812 | 23 693 312 |
2021-05-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −633 | 81 112 | −0,77 | 90,62 | −57 362 | 7 350 369 |
2021-05-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 023 | 81 745 | −1,24 | 89,51 | −91 569 | 7 316 995 |
2021-05-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −344 | 82 768 | −0,41 | 88,34 | −30 389 | 7 311 725 |
2021-05-11 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −152 | 244 530 | −0,06 | 105,08 | −15 972 | 25 695 212 | |
2021-05-11 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 243 | 244 682 | −0,51 | 103,68 | −128 874 | 25 368 630 | |
2021-05-11 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 800 | 245 925 | −0,73 | 102,35 | −184 230 | 25 170 424 | |
2021-05-11 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 300 | 247 725 | −0,52 | 101,10 | −131 430 | 25 044 998 | |
2021-05-11 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −802 | 249 025 | −0,32 | 100,33 | −80 465 | 24 984 678 | |
2021-05-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −175 | 83 112 | −0,21 | 137,63 | −24 085 | 11 438 705 |
2021-05-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 83 287 | −0,24 | 135,87 | −27 174 | 11 316 205 |
2021-05-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 83 487 | −0,36 | 135,14 | −40 542 | 11 282 433 |
2021-05-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 325 | 83 787 | −1,56 | 133,57 | −176 980 | 11 191 430 |
2021-04-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 249 827 | −0,12 | 131,19 | −39 357 | 32 774 804 |
2021-04-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −290 | 250 127 | −0,12 | 130,12 | −37 735 | 32 546 525 |
2021-04-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 250 417 | −0,12 | 129,08 | −38 724 | 32 323 826 |
2021-04-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 250 717 | −0,08 | 128,10 | −25 620 | 32 116 848 |
2021-04-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −310 | 250 917 | −0,12 | 127,02 | −39 376 | 31 871 477 |
2021-04-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −600 | 251 227 | −0,24 | 125,87 | −75 522 | 31 621 942 |
2021-04-19 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −560 | 85 112 | −0,65 | 125,42 | −70 235 | 10 674 747 |
2021-04-19 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −849 | 85 672 | −0,98 | 124,32 | −105 548 | 10 650 743 |
2021-04-19 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −391 | 86 521 | −0,45 | 123,11 | −48 136 | 10 651 600 |
2021-04-19 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 86 912 | −0,23 | 121,06 | −24 212 | 10 521 567 |
2021-04-07 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
A - Award | 13 635 | 13 635 | |||||
2021-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 87 112 | −0,23 | 118,43 | −23 686 | 10 316 674 |
2021-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 87 312 | −0,34 | 116,85 | −35 055 | 10 202 407 |
2021-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 87 612 | −0,23 | 114,68 | −22 936 | 10 047 344 |
2021-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −165 | 87 812 | −0,19 | 113,31 | −18 696 | 9 949 978 |
2021-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −800 | 87 977 | −0,90 | 112,48 | −89 984 | 9 895 653 |
2021-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −335 | 88 777 | −0,38 | 111,23 | −37 262 | 9 874 666 |
2021-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
M - Exercise | −14 919 | 44 759 | −25,00 | ||||
2021-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 14 919 | 251 827 | 6,30 | ||||
2021-03-25 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −500 | 236 908 | −0,21 | 129,40 | −64 700 | 30 655 895 |
2021-03-25 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 237 408 | −0,08 | 127,86 | −25 572 | 30 354 987 |
2021-03-25 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −441 | 237 608 | −0,19 | 127,09 | −56 047 | 30 197 601 |
2021-03-25 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 238 049 | −0,08 | 125,60 | −25 120 | 29 898 954 |
2021-03-25 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 238 249 | −0,04 | 124,24 | −12 424 | 29 600 056 |
2021-03-25 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −559 | 238 349 | −0,23 | 123,64 | −69 115 | 29 469 470 |
2021-03-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 89 112 | −0,22 | 132,81 | −26 562 | 11 834 965 |
2021-03-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −578 | 89 312 | −0,64 | 131,69 | −76 117 | 11 761 497 |
2021-03-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 89 890 | −0,11 | 130,18 | −13 018 | 11 701 880 |
2021-03-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 89 990 | −0,33 | 128,58 | −38 574 | 11 570 914 |
2021-03-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −622 | 90 290 | −0,68 | 127,39 | −79 237 | 11 502 043 |
2021-03-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 90 912 | −0,22 | 125,26 | −25 052 | 11 387 637 |
2021-03-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −400 | 91 112 | −0,44 | 139,75 | −55 900 | 12 732 902 |
2021-03-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 91 512 | −0,22 | 138,93 | −27 786 | 12 713 762 |
2021-03-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −202 | 91 712 | −0,22 | 138,16 | −27 908 | 12 670 930 |
2021-03-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 91 914 | −0,33 | 135,84 | −40 752 | 12 485 598 |
2021-03-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −798 | 92 214 | −0,86 | 134,42 | −107 267 | 12 395 406 |
2021-03-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 93 012 | −0,11 | 132,75 | −13 275 | 12 347 343 |
2021-02-24 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 238 908 | −0,08 | 141,62 | −28 324 | 33 834 151 |
2021-02-24 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 239 108 | −0,08 | 139,66 | −27 932 | 33 393 823 |
2021-02-24 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −402 | 239 308 | −0,17 | 139,21 | −55 962 | 33 314 067 |
2021-02-24 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 239 710 | −0,12 | 137,33 | −41 199 | 32 919 374 |
2021-02-24 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −598 | 240 010 | −0,25 | 135,74 | −81 173 | 32 578 957 |
2021-02-24 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 240 608 | −0,12 | 134,33 | −40 299 | 32 320 873 |
2021-02-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 93 112 | −0,11 | 160,60 | −16 060 | 14 953 787 |
2021-02-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 93 212 | −0,11 | 159,21 | −15 921 | 14 840 283 |
2021-02-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −692 | 93 312 | −0,74 | 158,82 | −109 903 | 14 819 812 |
2021-02-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −310 | 94 004 | −0,33 | 156,72 | −48 583 | 14 732 307 |
2021-02-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −798 | 94 314 | −0,84 | 155,32 | −123 945 | 14 648 850 |
2021-02-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 500 | 95 112 | −1,55 | 133,25 | −199 875 | 12 673 674 |
2021-02-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 96 612 | −0,21 | 131,34 | −26 268 | 12 689 020 |
2021-02-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 96 812 | −0,10 | 129,85 | −12 985 | 12 571 038 |
2021-02-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 96 912 | −0,21 | 126,88 | −25 376 | 12 296 195 |
2021-01-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 | 240 908 | 0,00 | 126,67 | −127 | 30 515 816 |
2021-01-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −999 | 240 909 | −0,41 | 125,31 | −125 185 | 30 188 307 |
2021-01-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −600 | 241 908 | −0,25 | 124,15 | −74 490 | 30 032 878 |
2021-01-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −400 | 242 508 | −0,16 | 123,03 | −49 212 | 29 835 759 |
2021-01-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 97 112 | −0,21 | 118,07 | −23 614 | 11 466 014 |
2021-01-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −400 | 97 312 | −0,41 | 116,34 | −46 536 | 11 321 278 |
2021-01-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −400 | 97 712 | −0,41 | 115,05 | −46 020 | 11 241 766 |
2021-01-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −500 | 98 112 | −0,51 | 114,14 | −57 070 | 11 198 504 |
2021-01-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −500 | 98 612 | −0,50 | 112,68 | −56 340 | 11 111 600 |
2021-01-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 99 112 | −0,20 | 140,15 | −28 030 | 13 890 547 |
2021-01-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −101 | 99 312 | −0,10 | 139,65 | −14 105 | 13 868 921 |
2021-01-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −498 | 99 413 | −0,50 | 138,16 | −68 804 | 13 734 900 |
2021-01-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −363 | 99 911 | −0,36 | 136,78 | −49 651 | 13 665 827 |
2021-01-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −838 | 100 274 | −0,83 | 135,82 | −113 817 | 13 619 215 |
2020-12-30 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 242 908 | −0,12 | 138,94 | −41 682 | 33 749 638 |
2020-12-30 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −831 | 243 208 | −0,34 | 137,82 | −114 528 | 33 518 927 |
2020-12-30 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −469 | 244 039 | −0,19 | 136,83 | −64 173 | 33 391 856 |
2020-12-30 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −400 | 244 508 | −0,16 | 135,51 | −54 204 | 33 133 279 |
2020-12-23 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −564 | 244 908 | −0,23 | 147,36 | −83 111 | 36 089 643 |
2020-12-23 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 245 472 | −0,12 | 145,74 | −43 722 | 35 775 089 |
2020-12-23 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −936 | 245 772 | −0,38 | 144,76 | −135 495 | 35 577 955 |
2020-12-23 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 246 708 | −0,08 | 143,55 | −28 710 | 35 414 933 |
2020-12-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −600 | 101 112 | −0,59 | 136,14 | −81 684 | 13 765 388 |
2020-12-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 200 | 101 712 | −1,17 | 135,13 | −162 156 | 13 744 343 |
2020-12-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 102 912 | −0,19 | 133,90 | −26 780 | 13 779 917 |
2020-12-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 103 112 | −0,29 | 120,61 | −36 183 | 12 436 338 |
2020-12-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 103 412 | −0,29 | 119,32 | −35 796 | 12 339 120 |
2020-12-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 103 712 | −0,29 | 118,02 | −35 406 | 12 240 090 |
2020-12-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 100 | 104 012 | −1,05 | 115,31 | −126 841 | 11 993 624 |
2020-11-30 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −200 | 246 750 | −0,08 | 120,69 | −24 138 | 29 780 258 | |
2020-11-30 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −6 701 | 246 950 | −2,64 | 119,87 | −803 249 | 29 601 896 | |
2020-11-30 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −2 232 | 253 651 | −0,87 | 119,19 | −266 032 | 30 232 663 | |
2020-11-30 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −19 687 | 0 | −100,00 | ||||
2020-11-30 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 19 687 | 255 883 | 8,34 | ||||
2020-11-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 100 | 105 112 | −1,04 | 114,55 | −126 005 | 12 040 580 |
2020-11-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −900 | 106 212 | −0,84 | 113,83 | −102 447 | 12 090 112 |
2020-11-10 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
M - Exercise | −350 | 0 | −100,00 | ||||
2020-11-10 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
A - Award | 350 | 350 | |||||
2020-11-10 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −144 | 235 996 | −0,06 | 100,40 | −14 458 | 23 693 998 | |
2020-11-10 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 350 | 236 140 | 0,15 | ||||
2020-11-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −764 | 107 112 | −0,71 | 76,72 | −58 614 | 8 217 633 |
2020-11-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 036 | 107 876 | −0,95 | 75,74 | −78 467 | 8 170 528 |
2020-11-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 108 912 | −0,18 | 74,66 | −14 932 | 8 131 370 |
2020-10-19 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −400 | 109 112 | −0,37 | 82,49 | −32 996 | 9 000 649 |
2020-10-19 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −500 | 109 512 | −0,45 | 81,32 | −40 660 | 8 905 516 |
2020-10-19 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 100 | 110 012 | −0,99 | 80,40 | −88 440 | 8 844 965 |
2020-10-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 111 112 | −0,18 | 72,25 | −14 450 | 8 027 842 |
2020-10-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 700 | 111 312 | −1,50 | 71,27 | −121 159 | 7 933 206 |
2020-10-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 113 012 | −0,09 | 69,87 | −6 987 | 7 896 148 |
2020-09-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −154 | 113 112 | −0,14 | 74,05 | −11 404 | 8 375 944 |
2020-09-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −800 | 113 266 | −0,70 | 73,15 | −58 520 | 8 285 408 |
2020-09-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 046 | 114 066 | −0,91 | 72,18 | −75 500 | 8 233 284 |
2020-09-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 115 112 | −0,17 | 79,92 | −15 984 | 9 199 751 |
2020-09-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 000 | 115 312 | −0,86 | 78,93 | −78 930 | 9 101 576 |
2020-09-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −800 | 116 312 | −0,68 | 77,93 | −62 344 | 9 064 194 |
2020-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 500 | 235 790 | −0,63 | 81,80 | −122 700 | 19 287 622 | |
2020-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −3 850 | 237 290 | −1,60 | 87,59 | −337 222 | 20 784 231 | |
2020-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −3 810 | 241 140 | −1,56 | 80,25 | −305 752 | 19 351 485 | |
2020-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −19 687 | 19 687 | −50,00 | ||||
2020-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 19 687 | 244 950 | 8,74 | ||||
2020-08-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 300 | 117 112 | −1,10 | 81,73 | −106 249 | 9 571 564 |
2020-08-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −700 | 118 412 | −0,59 | 79,54 | −55 678 | 9 418 490 |
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −69 | 225 263 | −0,03 | 79,27 | −5 470 | 17 856 598 | |
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
M - Exercise | −166 | 0 | −100,00 | ||||
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
A - Award | 166 | 166 | |||||
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 166 | 225 332 | 0,07 | ||||
2020-08-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −634 | 119 112 | −0,53 | 72,19 | −45 768 | 8 598 695 |
2020-08-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 119 746 | −0,08 | 70,66 | −7 066 | 8 461 252 |
2020-08-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −666 | 119 846 | −0,55 | 70,15 | −46 720 | 8 407 197 |
2020-08-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −400 | 120 512 | −0,33 | 68,62 | −27 448 | 8 269 533 |
2020-08-04 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 120 912 | −0,17 | 66,92 | −13 384 | 8 091 431 |
2020-07-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 121 112 | −0,25 | 78,62 | −23 586 | 9 521 825 |
2020-07-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 400 | 121 412 | −1,14 | 77,85 | −108 990 | 9 451 924 |
2020-07-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 122 812 | −0,24 | 75,98 | −22 794 | 9 331 256 |
2020-07-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 123 112 | −0,08 | 69,64 | −6 964 | 8 573 520 |
2020-07-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −480 | 123 212 | −0,39 | 68,98 | −33 110 | 8 499 164 |
2020-07-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 420 | 123 692 | −1,13 | 67,99 | −96 546 | 8 409 819 |
2020-06-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 140 | 125 112 | −0,90 | 74,39 | −84 805 | 9 307 082 |
2020-06-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −560 | 126 252 | −0,44 | 73,21 | −40 998 | 9 242 909 |
2020-06-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 126 812 | −0,24 | 71,69 | −21 507 | 9 091 152 |
2020-06-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 127 112 | −0,08 | 75,24 | −7 524 | 9 563 907 |
2020-06-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −500 | 127 212 | −0,39 | 74,37 | −37 185 | 9 460 756 |
2020-06-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −600 | 127 712 | −0,47 | 73,58 | −44 148 | 9 397 049 |
2020-06-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −800 | 128 312 | −0,62 | 72,15 | −57 720 | 9 257 711 |
2020-05-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −9 447 | 225 166 | −4,03 | 66,50 | −628 226 | 14 973 539 | |
2020-05-27 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −19 688 | 39 374 | −33,33 | ||||
2020-05-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 19 688 | 234 613 | 9,16 | ||||
2020-05-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −150 | 214 925 | −0,07 | 67,83 | −10 175 | 14 578 384 | |
2020-05-22 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
M - Exercise | −355 | 0 | −100,00 | ||||
2020-05-22 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
A - Award | 355 | 355 | |||||
2020-05-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 355 | 215 075 | 0,17 | ||||
2020-05-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 000 | 129 112 | −1,53 | 60,00 | −120 000 | 7 746 720 |
2020-05-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −6 000 | 131 112 | −4,38 | 60,00 | −360 000 | 7 866 720 |
2020-05-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −15 000 | 214 431 | −6,54 | 60,00 | −900 000 | 12 865 860 |
2020-04-23 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −22 372 | 229 431 | −8,88 | 40,98 | −916 805 | 9 402 082 |
2020-04-23 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −15 128 | 251 803 | −5,67 | 40,16 | −607 540 | 10 112 408 |
2020-04-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 100 | 266 931 | −1,15 | 41,46 | −128 526 | 11 066 959 |
2020-04-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −8 888 | 270 031 | −3,19 | 40,25 | −357 742 | 10 868 748 |
2020-04-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −22 812 | 278 919 | −7,56 | 39,75 | −906 777 | 11 087 030 |
2020-04-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 700 | 301 731 | −0,89 | 38,57 | −104 139 | 11 637 765 |
2020-04-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −400 | 304 431 | −0,13 | 44,30 | −17 720 | 13 486 293 |
2020-04-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −16 194 | 304 831 | −5,04 | 43,88 | −710 593 | 13 375 984 |
2020-04-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −20 906 | 321 025 | −6,11 | 42,79 | −894 568 | 13 736 660 |
2020-04-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 468 | 341 931 | −0,72 | 44,06 | −108 740 | 15 065 480 |
2020-04-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −25 656 | 344 399 | −6,93 | 43,45 | −1 114 753 | 14 964 137 |
2020-04-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −9 376 | 370 055 | −2,47 | 42,68 | −400 168 | 15 793 947 |
2020-04-13 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
A - Award | 59 678 | 59 678 | |||||
2020-04-02 |
|
4 | EVRG |
Evergy, Inc.
Director Deferred Share Units |
A - Award | 455 | 13 666 | 3,44 | ||||
2020-03-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −600 | 379 431 | −0,16 | 43,89 | −26 334 | 16 653 227 |
2020-03-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 640 | 380 031 | −0,95 | 42,60 | −155 064 | 16 189 321 |
2020-03-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 860 | 383 671 | −0,74 | 41,69 | −119 233 | 15 995 244 |
2020-03-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 100 | 386 531 | −0,28 | 40,50 | −44 550 | 15 654 506 |
2020-03-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 800 | 387 631 | −0,46 | 39,46 | −71 028 | 15 295 919 |
2020-03-25 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 000 | 137 112 | −0,72 | 30,52 | −30 520 | 4 184 658 |
2020-03-11 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 000 | 138 112 | −0,72 | 42,07 | −42 070 | 5 810 372 |
2020-03-11 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −300 | 389 431 | −0,08 | 43,95 | −13 185 | 17 115 492 | |
2020-03-11 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −7 160 | 389 731 | −1,80 | 43,31 | −310 100 | 16 879 250 | |
2020-03-02 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −19 688 | 59 062 | −25,00 | ||||
2020-03-02 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 19 688 | 396 891 | 5,22 | ||||
2020-02-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 377 203 | −0,05 | 92,56 | −18 512 | 34 913 910 |
2020-02-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 377 403 | −0,03 | 91,36 | −9 136 | 34 479 538 |
2020-02-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 377 503 | −0,05 | 90,17 | −18 034 | 34 039 446 |
2020-02-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 000 | 377 703 | −0,53 | 89,23 | −178 460 | 33 702 439 |
2020-02-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 803 | 379 703 | −0,73 | 88,49 | −248 037 | 33 599 918 |
2020-02-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 382 506 | −0,05 | 87,13 | −17 426 | 33 327 748 |
2020-02-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −581 | 382 706 | −0,15 | 85,47 | −49 658 | 32 709 882 |
2020-02-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 116 | 383 287 | −0,81 | 84,60 | −263 614 | 32 426 080 |
2020-02-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −800 | 386 403 | −0,21 | 83,44 | −66 752 | 32 241 466 |
2020-02-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 000 | 139 112 | −0,71 | 90,00 | −90 000 | 12 520 080 |
2020-02-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 000 | 140 112 | −0,71 | 93,58 | −93 580 | 13 111 681 |
2020-01-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 387 203 | −0,08 | 87,86 | −26 358 | 34 019 656 |
2020-01-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 092 | 387 503 | −0,28 | 87,14 | −95 157 | 33 767 011 |
2020-01-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 900 | 388 595 | −0,49 | 86,04 | −163 476 | 33 434 714 |
2020-01-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 900 | 390 495 | −0,99 | 85,21 | −332 319 | 33 274 079 |
2020-01-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 808 | 394 395 | −0,71 | 83,98 | −235 816 | 33 121 292 |
2020-01-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 141 112 | −0,07 | 87,24 | −8 724 | 12 310 611 |
2020-01-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −900 | 141 212 | −0,63 | 86,14 | −77 526 | 12 164 002 |
2020-01-08 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 000 | 142 112 | −0,70 | 66,61 | −66 610 | 9 466 080 |
2020-01-06 |
|
4 | EVRG |
Evergy, Inc.
Director Deferred Share Units |
A - Award | 2 383 | 13 089 | 22,26 | ||||
2019-12-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −760 | 396 750 | −0,19 | 64,93 | −49 347 | 25 760 978 |
2019-12-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −5 738 | 397 510 | −1,42 | 64,25 | −368 666 | 25 540 018 |
2019-12-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 502 | 403 248 | −0,86 | 63,04 | −220 766 | 25 420 754 |
2019-12-23 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 000 | 143 112 | −0,69 | 61,11 | −61 110 | 8 745 574 |
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −36 440 | 406 750 | −8,22 | 56,38 | −2 054 487 | 22 932 565 | |
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −39 375 | 78 750 | −33,33 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −39 375 | 78 750 | −33,33 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
A - Award | 78 750 | 157 500 | 100,00 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 39 375 | 443 190 | 9,75 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 39 375 | 443 190 | 9,75 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −4 366 | 364 440 | −1,18 | 57,31 | −250 215 | 20 886 056 |
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −800 | 368 806 | −0,22 | 56,16 | −44 928 | 20 712 145 |
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −4 834 | 369 606 | −1,29 | 55,08 | −266 257 | 20 357 898 |
2019-10-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −6 400 | 374 440 | −1,68 | 38,01 | −243 264 | 14 232 464 |
2019-10-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 600 | 380 840 | −0,94 | 37,43 | −134 748 | 14 254 841 |
2019-09-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 843 | 384 440 | −0,73 | 33,20 | −94 388 | 12 763 408 |
2019-09-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −7 157 | 387 283 | −1,81 | 32,48 | −232 459 | 12 578 952 |
2019-09-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −50 000 | 144 112 | −25,76 | 32,30 | −1 615 000 | 4 654 818 | |
2019-09-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −200 000 | 394 440 | −33,65 | 32,30 | −6 460 000 | 12 740 412 | |
2019-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
A - Award | 78 750 | 78 750 | |||||
2019-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −7 500 | 594 440 | −1,25 | 34,25 | −256 875 | 20 359 570 |
2019-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 500 | 601 940 | −0,41 | 33,42 | −83 550 | 20 116 835 |
2019-08-09 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −400 | 604 440 | −0,07 | 32,43 | −12 972 | 19 601 989 |
2019-08-09 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 010 | 604 840 | −0,33 | 31,33 | −62 973 | 18 949 637 |
2019-08-09 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 590 | 606 850 | −0,59 | 30,64 | −109 998 | 18 593 884 |
2019-07-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −4 000 | 610 440 | −0,65 | 28,52 | −114 080 | 17 409 749 |
2019-07-03 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −6 000 | 614 440 | −0,97 | 30,00 | −180 000 | 18 433 200 |
2019-06-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −4 000 | 620 440 | −0,64 | 23,76 | −95 040 | 14 741 654 |
2019-01-04 |
|
4 | EVRG |
Evergy, Inc.
Director Deferred Share Units |
A - Award | 2 290 | 10 378 | 28,31 | ||||
2018-12-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 | 623 357 | 0,00 | 13,71 | −14 | 8 546 224 | |
2018-12-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −14 452 | 623 358 | −2,27 | 13,32 | −192 501 | 8 303 129 | |
2018-12-12 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −75 000 | 0 | −100,00 | ||||
2018-12-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −12 900 | 637 810 | −1,98 | 13,69 | −176 601 | 8 731 619 | |
2018-12-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 75 000 | 650 710 | 13,03 | ||||
2018-12-07 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
A - Award | 75 000 | 75 000 | |||||
2018-08-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 445 | 573 787 | −0,25 | 20,66 | −29 854 | 11 854 439 | |
2018-06-22 |
|
4 | EVRG |
Evergy, Inc.
Director Deferred Share Units |
A - Award | 62 | 7 958 | 0,79 | ||||
2018-06-19 |
|
4 | EVRG |
Evergy, Inc.
Director Deferred Share Units |
A - Award | 737 | 7 896 | 10,29 | ||||
2018-06-06 |
|
4 | EVRG |
Evergy, Inc.
Director Deferred Share Units |
A - Award | 7 159 | 7 159 | |||||
2018-06-06 |
|
4 | EVRG |
Evergy, Inc.
Common Stock |
A - Award | 788 | 788 | |||||
2018-06-05 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Director Deferred Share Units |
D - Sale to Issuer | −11 970 | 0 | −100,00 | ||||
2018-06-05 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Common Stock |
D - Sale to Issuer | −1 318 | 0 | −100,00 | ||||
2018-05-29 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Director Deferred Share Units |
A - Award | 2 095 | 11 970 | 21,22 | ||||
2018-03-28 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Director Deferred Share Units |
A - Award | 723 | 9 875 | 7,90 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Series G' Redeemable Convertible Preferred Stock |
C - Conversion | −30 622 | 0 | −100,00 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Series G' Redeemable Convertible Preferred Stock |
M - Exercise | 1 279 | 30 622 | 4,36 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
M - Exercise | −1 279 | 0 | −100,00 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Series G' Redeemable Convertible Preferred Stock |
M - Exercise | 2 191 | 29 343 | 8,07 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
M - Exercise | −2 191 | 0 | −100,00 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Series G' Redeemable Convertible Preferred Stock |
M - Exercise | 1 183 | 27 152 | 4,56 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
M - Exercise | −1 183 | 0 | −100,00 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
P - Purchase | 800 | 800 | 13,00 | 10 400 | 10 400 | ||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
P - Purchase | 1 800 | 575 232 | 0,31 | 13,00 | 23 400 | 7 478 016 | |
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
C - Conversion | 30 622 | 573 432 | 5,64 | ||||
2018-02-08 | 3 | CDLX |
Cardlytics, Inc.
Common Stock |
1 279 732 | ||||||||
2018-02-08 | 3 | CDLX |
Cardlytics, Inc.
Common Stock |
931 034 | ||||||||
2018-02-08 | 3 | CDLX |
Cardlytics, Inc.
Common Stock |
1 279 732 | ||||||||
2018-02-08 | 3 | CDLX |
Cardlytics, Inc.
Common Stock |
931 034 | ||||||||
2017-12-28 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Director Deferred Share Units |
A - Award | 703 | 9 070 | 8,40 | ||||
2017-09-28 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Director Deferred Share Units |
A - Award | 746 | 8 297 | 9,88 | ||||
2017-06-29 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Director Deferred Share Units |
A - Award | 767 | 7 484 | 11,42 | ||||
2017-03-30 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Director Deferred Share Units |
A - Award | 692 | 6 655 | 11,60 | ||||
2016-12-29 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Director Deferred Share Units |
A - Award | 734 | 5 907 | 14,19 | ||||
2016-09-30 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Director Deferred Share Units |
A - Award | 719 | 5 122 | 16,33 | ||||
2016-06-29 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Director Deferred Share Units |
A - Award | 673 | 4 360 | 18,25 | ||||
2016-03-31 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Director Deferred Share Units |
A - Award | 621 | 3 655 | 20,47 | ||||
2015-12-30 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Director Deferred Share Units |
A - Award | 720 | 3 009 | 31,45 | ||||
2015-09-30 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Director Deferred Share Units |
A - Award | 762 | 2 267 | 50,63 | ||||
2015-06-30 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Director Deferred Share Units |
A - Award | 814 | 1 491 | 120,24 | ||||
2015-03-31 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Director Deferred Share Units |
A - Award | 670 | 670 | |||||
2014-12-30 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Common Stock |
A - Award | 596 | 1 318 | 82,55 | ||||
2014-09-30 |
|
4 | GXP |
GREAT PLAINS ENERGY INC
Common Stock |
A - Award | 722 | 722 |